Abstract:Reactive oxygen species (ROS) attract increasing interests due to the function of "double-edged sword" in physiological condition. In low concentration, ROS can benefit the growth of normal cells; however, in high concentration, they will induce cell apoptosis. Selenium is an essential trace element of human beings that can regulate the concentration of ROS. Previous work demonstrated the selective anti-cancer activity of coordinating assemblies consisting of selenium-containing amphiphile (EGSe) and cisplatin, but the structure and mechanism remain unclear. We synthesized another selenium-containing amphiphile-trimethyl-EGSe (EGSe-tMe) which has similar structure with EGSe but forms weaker interaction with platinum-containing compounds. Then, we prepared new coordinating assemblies composed of two types of selenium-containing amphiphiles and two types of platinum-containing compounds (cisplatin, platinum dichloride), in order to study the coordinating interaction between selenium and platinum. Additionally, we studied the mechanism of their selective anti-cancer activity by testing the ability of regulating ROS concentration in cancer cells and normal cells. We found that EGSe could coordinate with both cisplatin and platinum dichloride, resulting in the formation of coordinating assemblies with selective anti-cancer activity. However, coordinating assemblies consisting of EGSe-tMe and platinum-containing compounds showed little selectivity. These results indicate the important role of tight interaction between selenium and platinum played in the selective anti-cancer activity. The anti-cancer activity comes from their function of regulating the concentration of ROS in cells. Selenium-containing coordinating assemblies can raise higher concentration of ROS in cancer cells than in normal cells, thus causing selective toxicity to cancer cells. In further study, we proposed the mechanism of ROS production by selenium-containing coordinating assemblies. The coordinating assemblies can induce ROS production with the proof of electron spin resonance (ESR) measurement. We hope that this work can not only broaden the applications of selenium-containing coordinating assemblies in the field of cancer treatment, but also provide a new route for developing selective anti-cancer drugs.

The Interaction Between the Second Generation Anticancer Drug Carboplatin and L-Selenomethionine

Monitoring the Reactions of the Anticancer Drug Carboplatin with the Chemopreventive Agent Selenomethionine by Electrospray Mass Spectrometry and [1H,15N] HSQC NMR Spectroscopy

ESMS and NMR investigations on the interaction of the anticancer drug cisplatin and chemopreventive agent selenomethionine †

Fast Cleavage of a Diselenide Induced by a Platinum(ii)-Methionine Complex and Its Biological Implications.

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Chelate-ring-opened Adducts of [Pt(en)(me-Mal-o,o′)] (en = Ethane-1,2-diamine, Me-Mal = 2-Methylmalonate) with Methionine Derivatives: Relevance to the Biological Activity of Platinum Anticancer Agents

THE SYNTHESIS AND CHARACTERIZATION OF DINUCLEAR PLATINUM COMPLEXES BRIDGED BY DIPYRIDYL SELENIDES OR SULFIDES

From Preassociation to Chelation: A Survey of Cisplatin Interaction with Methionine at Molecular Level by IR Ion Spectroscopy and Computations

Determination of Binding Sites in Carboplatin-Bound Cytochrome C Using Electrospray Ionization Mass Spectrometry and Tandem Mass Spectrometry.

Fast Displacement of S,N-chelated L-Methionine in Platinum(ii) Complexes by Biological Thiols

Application Of High Performance Capillary Electrophoresis Tandem Mass Spectrometry To The Investigation On The Stability Of Novel Anticancer Platinum Complex In Solution

Selenium speciation studies in cancer patients to evaluate the responses of biomarkers of selenium status to different selenium compounds

Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance

Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1

Picoplatin binding to proteins: X-ray structures and mass spectrometry data on the adducts with lysozyme and ribonuclease A

Nanomedicine Assembled by Coordinated Selenium-Platinum Complexes Can Selectively Induce Cytotoxicity in Cancer Cells by Targeting the Glutathione Antioxidant Defense System

Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action

EFFECT OF ELEMENTAL SELENIUM AT NANO SIZE (Nano-Se) WITH LOWER TOXICITY ON THE ANTI-TUMOR EFFECT OF CISPLATIN

Novel polynuclear platinum adducts detected during the reactions of [Pt(Met-S,N)Cl2] with γ-glutathione and l-cysteine

Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects

Selenium-containing Coordinating Assemblies with Selective Anti-cancer Activity: the Control of Reactive Oxygen Species